Nanotechnologies for intranasal drug delivery: an update of literature

References

• Abbas Z, Swamy NGN. 2012. Mucoadhesive microspheres as intranasal drug delivery systems: a review. Ind Drugs. 49(1):5–23.
   Google Scholar
• Abdel Hady M, Sayed OM, Akl MA. 2020. Brain uptake and accumulation of new levofloxacin-doxycycline combination through the use of solid lipid nanoparticles: Formulation; Optimization and in-vivo evaluation. Colloids Surf B Biointerfaces. 193:111076.
   PubMed Web of Science ®Google Scholar
• Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, Alexander A. 2018. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release. 281:139–177.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Ahmad FJ, Ahmad W, Alam MA, Amir M, Ali A. 2020. Poloxamer-chitosan-based Naringenin nanoformulation used in brain targeting for the treatment of cerebral ischemia. Saudi J Biol Sci. 27(1):500–517.
   PubMed Web of Science ®Google Scholar
• Al Harthi S, Alavi SE, Radwan MA, El Khatib MM, AlSarra IA. 2019. Nasal delivery of donepezil HCl-loaded hydrogels for the treatment of Alzheimer’s. Sci Rep. 9(1):20.
   PubMedGoogle Scholar
• Alex AT, Joseph A, Shavi G, Rao JV, Udupa N. 2016. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery. Drug Deliv. 23(7):2144–2153.
   PubMed Web of Science ®Google Scholar
• Alexander A, Agrawal M, Uddin A, Siddique S, Shehata AM, Shaker MA, Ata Ur Rahman S, Abdul MIM, Shaker MA. 2019. Recent expansions of novel strategies towards the drug targeting into the brain. Int J Nanomedicine. 14:5895–5909.
   PubMed Web of Science ®Google Scholar
• Alexander A, Saraf S. 2018. Nose-to-brain drug delivery approach: a key to easily accessing the brain for the treatment of Alzheimer's disease. Neural Regen Res. 13(12):2102–2104.
   PubMed Web of Science ®Google Scholar
• Al-Halifa S, Gauthier L, Arpin D, Bourgault S, Archambault D. 2019. Nanoparticle-based vaccines against respiratory viruses. Front Immunol. 10:1–11.
   PubMed Web of Science ®Google Scholar
• Anderson GD, Saneto RP. 2012. Current oral and non-oral routes of antiepileptic drug delivery. Adv Drug Deliv Rev. 64(10):911–918.
   PubMed Web of Science ®Google Scholar
• Anton F, Peppel P. 1991. Central projections of trigeminal primary afferents innervating the nasal mucosa: A horseradish peroxidase study in the rat. Neurosci. 41(2-3):617–628.
   Web of Science ®Google Scholar
• Azegami T, Yuki Y, Sawada S, Mejima M, Ishige K, Akiyoshi K, Itoh H, Kiyono H. 2017. Nanogel-based nasal ghrelin vaccine prevents obesity. Mucosal Immunol. 10(5):1351–1360.
   PubMed Web of Science ®Google Scholar
• Azuar A, Zhao L, Hei TT, Nevagi RJ, Bartlett S, Hussein WM, Khalil ZG, Capon RJ, Toth I, Skwarczynski M, et al. 2019. Cholic acid-based delivery system for vaccine candidates against group A streptococcus. ACS Med Chem Lett. 10(9):1253–1259.
   PubMed Web of Science ®Google Scholar
• Beg S, Rahman M, Panda SK, Alharbi KS, Alruwaili NK, Ameeduzzafar , Singh PK, Thappa M, Singh B. 2020. Nasal Mucoadhesive microspheres of lercanidipine with improved systemic bioavailability and antihypertensive activity. J Pharm Innov. 16:237–246.
   Web of Science ®Google Scholar
• Bezerra IPS, Costa-Souza BLS, Carneiro G, Ferreira LAM, de Matos Guedes HL, Rossi-Bergmann B. 2019. Nanoencapsulated retinoic acid as a safe tolerogenic adjuvant for intranasal vaccination against cutaneous leishmaniasis. Vaccine. 37(28):3660–3667.
   PubMed Web of Science ®Google Scholar
• Bitter C, Suter K, Surber C. 2011. Nasal drug delivery in humans. Curr Probl Dermatol. 40:20–35.
   PubMedGoogle Scholar
• Bodor N, Brewster ME. 1982. Problems of delivery of drugs to the brain. Pharmacol. Ther. 19(3):337–386.
   PubMed Web of Science ®Google Scholar
• Bohr A, Tsapis N, Andreana I, Chamarat A, Foged C, Delomenie C, Noiray M, El Brahmi N, Majoral J-P, Mignani S, et al. 2017. Anti-inflammatory effect of anti-TNF-α SiRNA cationic phosphorus dendrimer nanocomplexes administered intranasally in a murine acute lung injury model. Biomacromolecules. 18(8):2379–2388.
   PubMed Web of Science ®Google Scholar
• Bonaccorso A, Musumeci T, Carbone C, Vicari L, Lauro MR, Puglisi G. 2018. Revisiting the role of sucrose in PLGA-PEG nanocarrier for potential intranasal delivery. Pharm Dev Technol. 23(3):265–274.
   PubMed Web of Science ®Google Scholar
• Bonferoni MC, Rossi S, Sandri G, Ferrari F, Gavini E, Rassu G, Giunchedi P. 2019. Nanoemulsions for "Nose-to-Brain. Drug Deliv Pharmac. 11(2):84.
   Google Scholar
• Chatterjee B, Gorain B, Mohananaidu K, Sengupta P, Mandal UK, Choudhury H. 2019. Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges. Int J Pharm. 565:258–268.
   PubMed Web of Science ®Google Scholar
• Chaturvedi M, Kumar M, Pathak K. 2011. A review on mucoadhesive polymer used in nasal drug delivery system. J Adv Pharm Technol Res. 2(4):215–222.
   PubMedGoogle Scholar
• Chen H-W, Huang C-Y, Lin S-Y, Fang Z-S, Hsu C-H, Lin J-C, Chen Y-I, Yao B-Y, Hu C-MJ. 2016. Synthetic virus-like particles prepared via protein corona formation enable effective vaccination in an avian model of coronavirus infection. Biomaterials. 106:111–118.
   PubMed Web of Science ®Google Scholar
• Chen Y, Cheng G, Hu R, Chen S, Lu W, Gao S, Xia H, Wang B, Sun C, Nie X, et al. 2019. A nasal temperature and pH dual-responsive in situ gel delivery system based on microemulsion of huperzine a: formulation, evaluation, and in vivo pharmacokinetic study. AAPS PharmSciTech. 20(7):301.
   PubMed Web of Science ®Google Scholar
• Chung K, Ullah I, Kim N, Lim J, Shin J, Lee SC, Jeon S, Kim SH, Kumar P, Lee S-K, et al. 2020. Intranasal delivery of cancer-targeting doxorubicin-loaded PLGA nanoparticles arrests glioblastoma growth. J Drug Target. 28(6):617–626.
   PubMed Web of Science ®Google Scholar
• Clementino A, Batger M, Garrastazu G, Pozzoli M, Del Favero E, Rondelli V, Gutfilen B, Barboza T, Sukkar MB, Souza SAL, et al. 2016. The nasal delivery of nanoencapsulated statins - an approach for brain delivery. Int J Nanomedicine. 11:6575–6590.
   PubMed Web of Science ®Google Scholar
• Cometa S, Bonifacio MA, Trapani G, Di Gioia S, Dazzi L, De Giglio E, Trapani A. 2020. In vitro investigations on dopamine loaded Solid Lipid Nanoparticles. J Pharm Biomed Anal. 185:113257.
   PubMed Web of Science ®Google Scholar
• Crowe TP, Greenlee MHW, Kanthasamy AG, Hsu WH. 2018. Mechanism of intranasal drug delivery directly to the brain. Life Sci. 195:44–52.
   PubMed Web of Science ®Google Scholar
• Cunha S, Amaral MH, Sousa Lobo JM, Silva AC. 2017. Lipid nanoparticles for nasal/intranasal drug delivery. Crit Rev Ther Drug Carrier Syst. 34(3):257–282.
   PubMed Web of Science ®Google Scholar
• Devadasu VR, Deb PK, Maheshwari R, Sharma P, Tekade RK. 2018. Chapter 5. Physicochemical, pharmaceutical, and biological considerations in GIT absorption of drugs. In: Tekade RK, editor. Dosage Form Design Considerations: Volume I (Advances in Pharmaceutical Product Development and Research). Academic Press, Cambridge, MA, USA; pp. 149–178.
   Google Scholar
• Dhaliwal HK, Fan Y, Kim J, Amiji MM. 2020. Intranasal delivery and transfection of mRNA therapeutics in the brain using cationic liposomes. Mol Pharm. 17(6):1996–2005.
   PubMedGoogle Scholar
• Dhuria SV, Hanson LR, Frey WH. 2010. Intranasal delivery to the central nervous system: Mechanisms and experimental considerations. J Pharm Sci. 99(4):1654–1673.
   PubMed Web of Science ®Google Scholar
• Diego-González L, Crecente-Campo J, Paul MJ, Singh M, Reljic R, Alonso MJ, González-Fernández Á, Simón-Vázquez R. 2020. Design of polymeric nanocapsules for intranasal vaccination against mycobacterium tuberculosis: Influence of the polymeric shell and antigen positioning. Pharmaceutics. 12(6):489–422.
   Web of Science ®Google Scholar
• Djupesland PG. 2018. Looking to the future of nasal drug delivery - an interview with Per Gisle Djupesland . Ther Deliv. 9(3):163–168.
   PubMed Web of Science ®Google Scholar
• Dkhar LK, Bartley J, White D, Seyfoddin A. 2018. Intranasal drug delivery devices and interventions associated with post-operative endoscopic sinus surgery. Pharm Dev Technol. 23(3):282–294.
   PubMed Web of Science ®Google Scholar
• Dogbe MG, Mafilaza AY, Eleutério CV, Cabral-Marques H, Simões S, Gaspar MM. 2019. Pharmaceutical benefits of fluticasone propionate association to delivery systems: In vitro and in vivo evaluation. Pharmaceutics. 11(10):521.
   Web of Science ®Google Scholar
• Du W, Li H, Tian B, Sai S, Gao Y, Lan T, Meng Y, Ding C. 2019. Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice. Colloids Surf B Biointerfaces. 183:110446.
   PubMed Web of Science ®Google Scholar
• Duchateau G, Zuidema J, Merkus FWHM. 1986. Bioavailability of Propranolol After Oral, Sublingual, and Intranasal Administration. Pharm Res. 03(2):108–111.
   Google Scholar
• Einer-Jensen N, Hunter RHF. 2005. Counter-current transfer in reproductive biology. Reproduction. 129(1):9–18.
   PubMed Web of Science ®Google Scholar
• El-Sherbiny IM, El-Baz NM, Yacoub MH. 2015. Inhaled nano- and microparticles for drug delivery. Glob Cardiol Sci Pract. 2015(1):2.
   PubMedGoogle Scholar
• Emami A, Tepper J, Short B, Yaksh TL, Bendele AM, Ramani T, Cisternas AF, Chang JH, Mellon RD. 2018. Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular. Int J Toxicol. 37(1):4–27.
   PubMed Web of Science ®Google Scholar
• Erdő F, Bors LA, Farkas D, Bajza A, Gizurarson S. 2018. Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res Bull. 143:155–170.
   PubMed Web of Science ®Google Scholar
• Escada PA, Lima C, Da Silva JM. 2009. The human olfactory mucosa. Eur Arch Otorhinolaryngol. 266(11):1675–1680.
   PubMed Web of Science ®Google Scholar
• Esim O, Savaser A, Karadurmus L, Bakirhan NK, Ozkan SA, Ozkan Y. 2021. Current status of drug delivery approaches and assay of anti-migraine drugs. Curr Drug Deliv. 18(2):121–146.
   PubMed Web of Science ®Google Scholar
• Esposito E, Cortesi R, Drechsler M, Fan J, Fu BM, Calderan L, Mannucci S, Boschi F, Nastruzzi C. 2017a. Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro/in vivo behavior. Eur J Pharm Biopharm. 115:285–296.
   PubMed Web of Science ®Google Scholar
• Esposito E, Drechsler M, Mariani P, Carducci F, Servadio M, Melancia F, Ratano P, Campolongo P, Trezza V, Cortesi R, et al. 2017b. Lipid nanoparticles for administration of poorly water soluble neuroactive drugs. Biomed Microdevices. 19(3):44.
   PubMed Web of Science ®Google Scholar
• Freitag FG, Shumate DA. 2016. The efficacy and safety of sumatriptan intranasal powder in adults with acute migraine. Expert Rev Neurother. 16(7):743–747.
   PubMed Web of Science ®Google Scholar
• Friedman BW, Holden L, Esses D, Bijur PE, Choi HK, Solorzano C, Paternoster J, Gallagher EJ. 2006. Parenteral corticosteroids for emergency department patients with non-radicular low back pain. J Emerg Med. 31(4):365–370.
   PubMed Web of Science ®Google Scholar
• Fukuyama Y, Yuki Y, Katakai Y, Harada N, Takahashi H, Takeda S, Mejima M, Joo S, Kurokawa S, Sawada S, et al. 2015. Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques. Mucosal Immunol. 8(5):1144–1153.
   PubMed Web of Science ®Google Scholar
• Gadhave DG, Kokare CR. 2019. Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies. Drug Dev Ind Pharm. 45(5):839–851.
   PubMed Web of Science ®Google Scholar
• Gadhave DG, Tagalpallewar AA, Kokare CR. 2019. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies. AAPS PharmSciTech. 20(1):22–15.
   PubMed Web of Science ®Google Scholar
• Galeano C, Qiu Z, Mishra A, Farnsworth SL, Hemmi JJ, Moreira A, Edenhoffer P, Hornsby PJ. 2018. The Route by Which Intranasally Delivered Stem Cells Enter the Central Nervous System. Cell Transplant. 27(3):501–514.
   PubMed Web of Science ®Google Scholar
• Gänger S, Schindowski K. 2018. Tailoring formulations for intranasal nose-to-brain delivery: A review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics. 10(3):116.
   PubMed Web of Science ®Google Scholar
• Gao L, Yang ST, Li S, Meng Y, Wang H, Lei H. 2013. Acute toxicity of zinc oxide nanoparticles to the rat olfactory system after intranasal instillation. J Appl Toxicol. 33(10):1079–1088.
   PubMed Web of Science ®Google Scholar
• Giuliani A, Balducci AG, Zironi E, Colombo G, Bortolotti F, Lorenzini L, Galligioni V, Pagliuca G, Scagliarini A, Calzà L, et al. 2018. In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates. Drug Deliv. 25(1):376–387.
   PubMed Web of Science ®Google Scholar
• Gizurarson S. 2012. Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery. Curr Drug Deliv. 9(6):566–582.
   PubMed Web of Science ®Google Scholar
• Gosselet F. 2017. [Modelling of the blood-brain barrier]. Med Sci (Paris)). 33(4):423–431.
   PubMed Web of Science ®Google Scholar
• Graff CL, Zhao R, Pollack GM. 2005. Pharmacokinetics of substrate uptake and distribution in murine brain after nasal instillation. Pharm Res. 22(2):235–244.
   PubMed Web of Science ®Google Scholar
• Gwinn MR, Vallyathan V. 2006. Nanoparticles: Health effects - Pros and cons. Environ Health Perspect. 114(12):1818–1825.
   PubMed Web of Science ®Google Scholar
• Herman TF, Santos C. 2019. First pass effect. Treasure Island (FL, USA): StatPearls.
   Google Scholar
• Heshmati F, Noroozinia H, Abbasivash R, Gharaee H. 2006. Intranasal sufentanil for postoperative pain control in lower abdominal pediatric surgery. Iran J Pharmacol Ther. 5:131–133.
   Google Scholar
• Hopkins LE, Patchin ES, Chiu PL, Brandenberger C, Smiley-Jewell S, Pinkerton KE. 2014. Nose-to-brain transport of aerosolised quantum dots following acute exposure. Nanotoxicology. 8(8):885–893.
   PubMed Web of Science ®Google Scholar
• Hussein N, Omer H, Ismael A, Albed Alhnan M, Elhissi A, Ahmed W. 2020. Spray-dried alginate microparticles for potential intranasal delivery of ropinirole hydrochloride: development, characterization and histopathological evaluation. Pharm Dev Technol. 25(3):290–299.
   PubMed Web of Science ®Google Scholar
• Illum L. 2003. Nasal drug delivery-possibilities, problems and solutions. J Control Rel. 87(1-3):187–198.
   PubMed Web of Science ®Google Scholar
• Ingrole RSJ, Gill HS. 2019. Special section on drug delivery technologies — minireview microneedle coating methods: a review with a perspective. J Pharmacol Exp Ther. 370(3):555–569.
   PubMed Web of Science ®Google Scholar
• Iqbal MA, Md S, Sahni JK, Baboota S, Dang S, Ali J. 2012. Nanostructured lipid carriers system: recent advances in drug delivery. J Drug Target. 20(10):813–830.
   PubMed Web of Science ®Google Scholar
• Itani R, Tobaiqy M, Al Faraj A. 2020. Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients. Theranostics. 10(13):5932–5942.
   PubMed Web of Science ®Google Scholar
• Jadhav K, Gambhire M, Shaikh I, Kadam V, Pisal S. 2007. Nasal drug delivery system-factors affecting and applications. CDTH. 2(1):27–38.
   Google Scholar
• Jain K, Mehra NK, Jain NK. 2015. Nanotechnology in drug delivery: safety and toxicity issues. Curr Pharm Des. 21(29):4252–4261.
   PubMed Web of Science ®Google Scholar
• Jazuli I, Annu , Nabi B, Moolakkadath T, Alam T, Baboota S, et al. 2019. Optimization of nanostructured lipid carriers of lurasidone hydrochloride using box-behnken design for brain targeting: in vitro and in vivo studies. J Pharm Sci. 108:3082–3090.
   PubMed Web of Science ®Google Scholar
• Jojo GM, Kuppusamy G, De A, Karri V. 2019. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design. Drug Dev Ind Pharm. 45(7):1061–1072.
   PubMed Web of Science ®Google Scholar
• Jones DS, Craig DQM. 2010. The Journal of Pharmacy and Pharmacology - four years on. J Pharm Pharmacol. 56(1):1–2.
   Google Scholar
• Jose S, Ansa CR, Cinu TA, Chacko AJ, Aleykutty NA, Ferreira SV, Souto EB. 2013. Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting. Int J Pharm. 441(1-2):516–526.
   PubMed Web of Science ®Google Scholar
• Jurišić Dukovski B, Mrak L, Winnicka K, Szekalska M, Juretić M, Filipović-Grčić J, Pepić I, Lovrić J, Hafner A. 2019. Spray-dried nanoparticle-loaded pectin microspheres for dexamethasone nasal delivery. Dry Technol. 37(15):1915–1925.
   Web of Science ®Google Scholar
• Kashyap N, Mishra A, Pathak AK, Kashyap N. 2019. Inclusion of Hydrophilic-Lipophilic Balance (HLB) in the treatment of Psoriasis-A new approach. Int J Adv Pharm. [Internet]. 8(1):e5150.
   Google Scholar
• Katare YK, Daya RP, Sookram Gray C, Luckham RE, Bhandari J, Chauhan AS, Mishra RK. 2015. Brain targeting of a water insoluble antipsychotic drug haloperidol via the intranasal route using PAMAM dendrimer. Mol Pharm. 12(9):3380–3388.
   PubMedGoogle Scholar
• Katdare A, Khunt D, Thakkar S, Polaka SN, Misra M. 2020. Comparative evaluation of fish oil and butter oil in modulating delivery of galantamine hydrobromide to brain via intranasal route: pharmacokinetic and oxidative stress studies. Drug Deliv Transl Res. 10(4):1136–1146.
   PubMed Web of Science ®Google Scholar
• Katsarov P, Pilicheva B, Uzunova Y, Gergov G, Kassarova M. 2018. Chemical cross-linking: A feasible approach to prolong doxylamine/pyridoxine release from spray-dried chitosan microspheres. Eur J Pharm Sci. 123:387–394.
   PubMed Web of Science ®Google Scholar
• Kaur A, Nigam K, Bhatnagar I, Sukhpal H, Awasthy S, Shankar S, et al. 2020. Treatment of Alzheimer’s diseases using donepezil nanoemulsion: an intranasal approach. Drug Deliv Transl Res. 10(6):1862–1875.
   PubMed Web of Science ®Google Scholar
• Kaurav H, Hari Kumar SL, Kaur A. 2012. Mucoadhesive microspheres as carriers in drug delivery: a review. Int J Drug Dev Res. 4:21–34.
   Google Scholar
• Khan AR, Liu M, Khan MW, Zhai G. 2017. Progress in brain targeting drug delivery system by nasal route. J Control Release. 268:364–389.
   PubMed Web of Science ®Google Scholar
• Khan M, Ansari VA, Kushwaha P, Kumar A, Akhtar J. 2015. Mucoadhesive microspheres for controlled delivery of drugs. Asian J Pharm Clin Res. 8:17–20.
   Google Scholar
• Khan R, Prajapati SK, Irchhiaya R, Singh G. 2010. Formulation and evaluation of mucoadhesive microspheres of Flurbiprofen. Pharmacologyonline. 3:659–670.
   Google Scholar
• Khan S, Gangane PS, Mahapatra DK, Mahajan NM. 2019. Natural and synthetic polymers assisted development of lurasidone hydrochloride intranasal mucoadhesive microspheres. IJPER. 54(1):213–222.
   Google Scholar
• Khunt D, Shrivas M, Polaka S, Gondaliya P, Misra M. 2020. Role of omega-3 fatty acids and butter oil in targeting delivery of donepezil hydrochloride microemulsion to brain via the intranasal route: a comparative study. AAPS PharmSciTech. 21(2):45.
   PubMed Web of Science ®Google Scholar
• Kumar M, Nishad DK, Kumar A, Bhatnagar A, Karwasra R, Khanna K, Keerthana S, Sharma D, Dua K, Mudaliyar V, et al. 2020. Enhancement in brain uptake of Vitamin D3 nanoemulsion for treatment of cerebral ischemia: Formulation, Gamma scintigraphy and efficacy study in transient middle cerebral artery occlusion rat models. J Microencapsul. 37(7):492–501.
   PubMed Web of Science ®Google Scholar
• Kumar M, Upadhayay P, Shankar R, Joshi M, Bhatt S, Malik A. 2019. Chlorpheniramine maleate containing chitosan-based nanoparticle-loaded thermosensitive in situ gel for management in allergic rhinitis. Drug Deliv Transl Res. 9(6):1017–1026.
   PubMed Web of Science ®Google Scholar
• Kumar S, Choudhary M. 2018. Microspheres as controlled drug delivery system: an updated. Int J Pharm Sci Res. 9:1760–1768.
   Web of Science ®Google Scholar
• Kumbhar SA, Kokare CR, Shrivastava B, Gorain B, Choudhury H. 2020. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: in vitro and in vivo studies for brain targeting. Int J Pharm. 586:119499.
   PubMedGoogle Scholar
• Kwan K. 2015. Oral bioavailability and first-pass effects. J Neurol Neurosurg Psychiatry. 86:1329–1336.
   Google Scholar
• Lai X, Zhao H, Zhang Y, Guo K, Xu Y, Chen S, Zhang J. 2018. Intranasal delivery of copper oxide nanoparticles induces pulmonary toxicity and fibrosis in C57BL/6 mice. Sci Rep. 8(1):12.
   PubMedGoogle Scholar
• Lataste X. 1992. The blood-brain barrier in hypoxia. Int J Sports Med. 13(S 1):S45–S47.
   PubMedGoogle Scholar
• Lavik EB, Kuppermann BD, Humayun MS, et al. 2013. Chapter 38 - drug delivery. In: Ryan SJ, Sadda SR, Hinton DR, Schachat AP, Sadda SR, Wilkinson CP, editors. London: W.B. Saunders. p. 734–745.
   Google Scholar
• Li H-S, Shin M-K, Singh B, Maharjan S, Park T-E, Kang S-K, Yoo H-S, Hong Z-S, Cho C-S, Choi Y-J, et al. 2016. Nasal immunization with mannan-decorated mucoadhesive HPMCP microspheres containing ApxIIA toxin induces protective immunity against challenge infection with Actinobacillus pleuropneumoiae in mice. J Control Release. 233:114–125.
   PubMed Web of Science ®Google Scholar
• Li H-S, Singh B, Park T-E, Hong Z-S, Kang S-K, Cho C-S, Choi Y-J. 2015. Mannan-decorated thiolated Eudragit microspheres for targeting antigen presenting cells via nasal vaccination. Eur J Pharm Sci. 80:16–25.
   PubMed Web of Science ®Google Scholar
• Li L, Gorukanti S, Choi YM, Kim KH. 2000. Rapid-onset intranasal delivery of anticonvulsants: pharmacokinetic and pharmacodynamic evaluation in rabbits. Int J Pharm. 199(1):65–76.
   PubMedGoogle Scholar
• Lu C-T, Zhao Y-Z, Wong OL, Cai J, Peng L, Tian K-Q. 2014. Current approaches to enhance CNS delivery of drugs across the brain barriers. Int J Nanomed. 9:2241–2257.
   PubMed Web of Science ®Google Scholar
• Maheshwari R, Kuche K, Mane A, Chourasiya Y, Tekade M, Tekade RK. 2018. Manipulation of physiological processes for pharmaceutical product development. In Tekade RT, editor. Advances in pharmaceutical product development and research, dosage form design considerations. Cambridge (MA, USA): Academic Press. pp. 701–729.
   Google Scholar
• Mai Y, Guo J, Zhao Y, Ma S, Hou Y, Yang J. 2020. Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity. Cell Immunol. 354:104–143.
   Web of Science ®Google Scholar
• Mandal S, Das Mandal S, Chuttani K, Sawant KK, Subudhi BB. 2018. Preclinical study of ibuprofen loaded transnasal mucoadhesive microemulsion for neuroprotective effect in MPTP mice model. Iran J Pharm Res. 17:23–38.
   PubMed Web of Science ®Google Scholar
• Mantry S, Balaji A. 2017. Formulation design and characterization of ropinirole hydrochoride microsphere for intranasal delivery. Asian J Pharm Clin Res. 10(7):195–203.
   Google Scholar
• Marx D, Williams G, Birkhoff M. 2015. Intranasal drug administration- an attractive delivery route for some drugs. In: Vallisuta O, Olimat S, editors. Drug discovery and development - from molecules to medicine, London: IntechOpen, Ltd.
   Google Scholar
• McClellan G. 2009. The region of the nose and nasal cavities. Regional Anatomy McClellan, George 1896, 1:5. https://jdc.jefferson.edu/regional_anatomy/5.
   Google Scholar
• Meng Q, Wang A, Hua H, Jiang Y, Wang Y, Mu H, Wu Z, Sun K. 2018. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease. Int J Nanomedicine. 13:705–718.
   PubMed Web of Science ®Google Scholar
• Mishra N, Sharma S, Deshmukh R, Kumar A, Sharma R. 2019. Development and Characterization of Nasal Delivery of Selegiline Hydrochloride Loaded Nanolipid Carriers for the Management of Parkinson's Disease. Cent Nerv Syst Agents Med Chem. 19(1):46–56.
   PubMedGoogle Scholar
• Morano A, Iannone L, Palleria C, Fanella M, Giallonardo AT, De Sarro G, Russo E, Di Bonaventura C. 2019. Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy. Expert Opin Pharmacother. 20(1):25–39.
   PubMed Web of Science ®Google Scholar
• Murphy CJ, Gole AM, Stone JW, Sisco PN, Alkilany AM, Goldsmith EC, Baxter SC. 2008. Gold nanoparticles in biology: Beyond toxicity to cellular imaging. Acc Chem Res. 41(12):1721–1730.
   PubMed Web of Science ®Google Scholar
• Nair KGS, Ramaiyan V, Sukumaran SK. 2018. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis. Inflammopharmacology. 26(3):675–684.
   PubMed Web of Science ®Google Scholar
• Nanaki S, Tseklima M, Christodoulou E, Triantafyllidis K, Kostoglou M, Bikiaris DN. 2017. Thiolated chitosan masked polymeric microspheres with incorporated mesocellular silica foam (MCF) for intranasal delivery of paliperidone. Polymers (Basel. 9(11):617.
   Web of Science ®Google Scholar
• Nezhat CR, Nezhat FR, Metzger DA, Luciano AA. 1990. Adhesion reformation after reproductive surgery by videolaseroscopy. Fertil Steril. 53(6):1008–1011.
   PubMed Web of Science ®Google Scholar
• Nimesh S. 2013. Dendrimers. In: Nimesh S, editor. Cambridge (UK): Woodhead publishing series in biomaterials, Gene Therapy, Woodhead Publishing. p. 259–285.
   Google Scholar
• Nižić L, Potaś J, Winnicka K, Szekalska M, Erak I, Gretić M, Jug M, Hafner A. 2020. Development, characterisation and nasal deposition of melatonin-loaded pectin/hypromellose microspheres. Eur J Pharm Sci. 141:105115.
   PubMed Web of Science ®Google Scholar
• Oliveira P, Fortuna A, Alves G, Falcão A. 2016. Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs. Curr Drug Metab. 17(7):628–647.
   PubMed Web of Science ®Google Scholar
• Omar MM, Eleraky NE, El Sisi AM, Hasan OA. 2019. Development and evaluation of in-situ nasal gel formulations of nanosized transferosomal sumatriptan: Design, optimization, in vitro and in vivo evaluation. Drug Des Devel Ther. 13:4413–4430.
   PubMed Web of Science ®Google Scholar
• Ozsoy Y, Gungor S, Cevher E. 2009. Nasal delivery of high molecular weight drugs. Molecules. 14(9):3754–3779.
   PubMed Web of Science ®Google Scholar
• Pandey P, Pandey S, Cabot PJ, Wallwork B, Panizza BJ, Parekh HS. 2019. Toxicity evaluation and nasal mucosal tissue deposition of dexamethasone-infused mucoadhesive in situ nasal gelling systems. Saudi Pharm J. 27(7):914–919.
   PubMed Web of Science ®Google Scholar
• Parveen A, Rizvi SHM, Gupta A, Singh R, Ahmad I, Mahdi F, Mahdi AA. 2012. NMR-based metabonomics study of sub-acute hepatotoxicity induced by silica nanoparticles in rats after intranasal exposure. Cell Mol Biol (Noisy-le-Grand). 58(1):196–203.
   PubMed Web of Science ®Google Scholar
• Patel MM, Patel BM. 2017. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain. CNS Drugs. 31(2):109–133.
   PubMed Web of Science ®Google Scholar
• Patel RG. 2017. Nasal Anatomy and Function. Facial Plast Surg. 33(1):3–8.
   PubMed Web of Science ®Google Scholar
• Patel RJ, Parikh RH. 2020. Intranasal delivery of topiramate nanoemulsion: pharmacodynamic, pharmacokinetic and brain uptake studies. Int J Pharm. 585(119486):119486.
   PubMedGoogle Scholar
• Pathak C, Vaidya FU, Pandey SM. 2019. Mechanism for development of nanobased drug delivery system. In: Mohapatra SS, Ranjan S, Dasgupta N, Mishra RK, Thomas S, editors. Micro and Nano Technologies, Applications of Targeted Nano Drugs and Delivery Systems, Shannon, Ireland: Elsevier; p. 35–67.
   Google Scholar
• Pereswetoff-Morath L. 1998. Microspheres as nasal drug delivery systems. Adv Drug Deliv Rev. 29(1-2):185–194.
   PubMed Web of Science ®Google Scholar
• Picone P, Sabatino MA, Ditta LA, Amato A, San Biagio PL, Mulè F, Giacomazza D, Dispenza C, Di Carlo M. 2018. Nose-to-brain delivery of insulin enhanced by a nanogel carrier. J Control Release. 270:23–36.
   PubMed Web of Science ®Google Scholar
• Pires A, Fortuna A, Alves G, Falcão A. 2009. Intranasal drug delivery: how, why and what for? J Pharm Pharm Sci. 12(3):288–311.
   PubMed Web of Science ®Google Scholar
• Popescu R, Ghica MV, Dinu-Pîrvu C-E, Anuța V, Lupuliasa D, Popa L. 2020. New opportunity to formulate intranasal vaccines and drug delivery systems based on chitosan. IJMS. 21(14):5016.
   Google Scholar
• Pourtalebi-Jahromi L, Mohammadi Samani S, Heidari R, Azadi A. 2018. in vitro- and in vivo Evaluation of Methotrexate-Loaded Hydrogel Nanoparticles Intended to Treat Primary CNS Lymphoma via Intranasal Administration. J Pharm Pharm Sci. 21(1):305–317.
   PubMedGoogle Scholar
• Praveen A, Aqil M, Imam SS, Ahad A, Moolakkadath T, Ahmad FJ. 2019. Lamotrigine encapsulated intra-nasal nanoliposome formulation for epilepsy treatment: Formulation design, characterization and nasal toxicity study. Colloids Surf B Biointerfaces. 174:553–562.
   PubMed Web of Science ®Google Scholar
• Propst CN, Nwabueze AO, Kanev IL, Pepin RE, Gutting BW, Morozov VN, van Hoek ML. 2016. Nanoaerosols reduce required effective dose of liposomal levofloxacin against pulmonary murine Francisella tularensis subsp. novicida infection. J Nanobiotechnol. 14(1):10.
   PubMedGoogle Scholar
• Quadir M, Zia H, Needham TE. 1999. Toxicological implications of nasal formulations. Drug Deliv J Deliv Target Ther Agents. 6(4):227–242.
   Google Scholar
• Quintana DS, Westlye LT, Alnaes D, Rustan ØG, Kaufmann T, Smerud KT, Mahmoud RA, Djupesland PG, Andreassen OA. 2016. Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial. Psychoneuroendocrinology. 69:180–188.
   PubMed Web of Science ®Google Scholar
• Quintana DS, Westlye LT, Rustan ØG, Tesli N, Poppy CL, Smevik H, Tesli M, Røine M, Mahmoud RA, Smerud KT, et al. 2015. Low dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: A randomized fourway crossover trial with nasal cavity dimension assessment. Transl Psychiatry. 5(7):e602
   PubMedGoogle Scholar
• Ramreddy S, Janapareddi K. 2019. Brain targeting of chitosan-based diazepam mucoadhesive microemulsions via nasal route: formulation optimization, characterization, pharmacokinetic and pharmacodynamic evaluation. Drug Dev Ind. 45(1):147–158.
   PubMed Web of Science ®Google Scholar
• Rassu G, Porcu EP, Fancello S, Obinu A, Senes N, Galleri G, Migheli R, Gavini E, Giunchedi P. 2018. Intranasal delivery of genistein-loaded nanoparticles as a potential preventive system against neurodegenerative disorders. Pharmaceutics. 11(1):8.
   PubMed Web of Science ®Google Scholar
• Rassu G, Soddu E, Posadino AM, Pintus G, Sarmento B, Giunchedi P, Gavini E. 2017. Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer's therapy. Colloids Surf B Biointerfaces. 152:296–301.
   PubMed Web of Science ®Google Scholar
• Rech MA, Barbas B, Chaney W, Greenhalgh E, Turck C. 2017. When to Pick the Nose: Out-of-Hospital and Emergency Department Intranasal Administration of Medications. Ann Emerg Med. 70(2):203–211.
   PubMed Web of Science ®Google Scholar
• Renner DB, Svitak AL, Gallus NJ, Ericson ME, Frey IIW, Hanson LR. 2012. Intranasal delivery of insulin via the olfactory nerve pathway. J Pharm Pharmacol. 64(12):1709–1714.
   PubMed Web of Science ®Google Scholar
• Rinaldi F, Oliva A, Sabatino M, Imbriano A, Hanieh PN, Garzoli S, Mastroianni CM, De Angelis M, Miele MC, Arnaut M, et al. 2020. Antimicrobial essential oil formulation: Chitosan coated nanoemulsions for nose to brain delivery. Pharmaceutics. 12(7):678–618.
   Web of Science ®Google Scholar
• Rodríguez-Fonseca RA, Bello M, de los Muñoz-Fernández MÁ, Luis Jiménez J, Rojas-Hernández S, Fragoso-Vázquez MJ, Gutiérrez-Sánchez M, Rodrigues J, Cayetano-Castro N, Borja-Urby R, et al. 2019. In silico search, chemical characterization and immunogenic evaluation of amino-terminated G4-PAMAM-HIV peptide complexes using three-dimensional models of the HIV-1 gp120 protein. Colloids Surf B Biointerfaces. 177:77–93.
   PubMed Web of Science ®Google Scholar
• Rudokas M, Najlah M, Alhnan MA, Elhissi A. 2016. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications. Med Princ Pract. 25(2):60–72.
   PubMedGoogle Scholar
• Sabale A, Kulkarni A, Sabale A. 2020. Nasal In Situ Gel: Novel Approach for Nasal Drug Delivery. J Drug Delivery Ther. 10(2-s):183–197.
   Google Scholar
• Salem LH, El-Feky GS, Fahmy RH, El Gazayerly ON, Abdelbary A. 2020. Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule. J Pharm Sci. 109(7):2237–2251.
   PubMed Web of Science ®Google Scholar
• Sapra B, Thatai P, Bhandari S, Sood J, Jindal M, Tiwary AK. 2014. A critical appraisal of microemulsions for drug delivery: part II. Ther Deliv. 5(1):83–94.
   PubMedGoogle Scholar
• Sarkar MA. 1992. Drug metabolism in the nasal mucosa. Pharm Res. 9(1):1–9.
   PubMed Web of Science ®Google Scholar
• Schwarz B, Morabito KM, Ruckwardt TJ, Patterson DP, Avera J, Miettinen HM, Graham BS, Douglas T. 2016. Viruslike Particles Encapsidating Respiratory Syncytial Virus M and M2 Proteins Induce Robust T Cell Responses. ACS Biomater Sci Eng. 2(12):2324–2332.
   PubMed Web of Science ®Google Scholar
• Scoville DK, White CC, Botta D, An D, Afsharinejad Z, Bammler TK, Gao X, Altemeier WA, Kavanagh TJ. 2018. Quantum dot induced acute changes in lung mechanics are mouse strain dependent. Inhal Toxicol. 30(9-10):397–403.
   PubMed Web of Science ®Google Scholar
• Selvaraj K, Gowthamarajan K, Karri VVSR. 2018. Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting. Artif Cells Nanomed Biotechnol. 46(8):2088–2095.
   PubMed Web of Science ®Google Scholar
• Shah B, Khunt D, Bhatt H, Misra M, Padh H. 2015. Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parameters. Eur J Pharm Sci. 78:54–66.
   PubMed Web of Science ®Google Scholar
• Shah B, Khunt D, Misra M, Padh H. 2018. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting. Pharm Res. 35(1):8.
   PubMed Web of Science ®Google Scholar
• Shah V, Sharma M, Pandya R, Parikh RK, Bharatiya B, Shukla A, Tsai H-C. 2017. Quality by Design approach for an in situ gelling microemulsion of Lorazepam via intranasal route. Mater Sci Eng C Mater Biol Appl. 75:1231–1241.
   PubMed Web of Science ®Google Scholar
• Shahzad F, Bano I, Mubarak B, Rathore AW, Aziz S. 2016. Effect of inhaled corticosteroids on growth of asthmatic children. Pakistan Paediatr J. 40:153–158.
   Google Scholar
• Shelke R, Devarajan P. 2007. Aqua triggered in situ gelling microemulsion for nasal delivery. Indian J Pharm Sci. 69:726–727.
   Google Scholar
• Shim S, Soh SH, Im YB, Ahn C, Park H-T, Park H-E, Park WB, Kim S, Yoo HS. 2020. Induction of systemic immunity through nasal-associated lymphoid tissue (NALT) of mice intranasally immunized with Brucella abortus malate dehydrogenase-loaded chitosan nanoparticles. PLoS One. 15(2):e0228463–18.
   PubMed Web of Science ®Google Scholar
• Shinde RL, Devarajan PV. 2017. Docosahexaenoic acid–mediated, targeted and sustained brain delivery of curcumin microemulsion. Drug Deliv. 24(1):152–161.
   PubMed Web of Science ®Google Scholar
• Singh AP, Saraf SK, Saraf SA. 2012. SLN approach for nose-to-brain delivery of alprazolam. Drug Deliv Transl Res. 2(6):498–507.
   PubMed Web of Science ®Google Scholar
• Stratilo CW, Jager S, Crichton M, Blanchard JD. 2020. Evaluation of liposomal ciprofloxacin formulations in a murine model of anthrax. PLoS One. 15(1):e0228162.
   PubMed Web of Science ®Google Scholar
• Striebel HW, Bonillo B, Schwagmeier R, Dopjans D, Spies C. 1995. Self-administered intranasal meperidine for postoperative pain management. Can J Anaesth. 42(4):287–291.
   PubMed Web of Science ®Google Scholar
• Sukumar UK, Bose RJC, Malhotra M, Babikir HA, Afjei R, Robinson E, Zeng Y, Chang E, Habte F, Sinclair R, et al. 2019. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide. Biomaterials. 218:119342.
   PubMed Web of Science ®Google Scholar
• Sun Y, Li L, Xie H, Wang Y, Gao S, Zhang L, Bo F, Yang S, Feng A. 2020. Primary studies on construction and evaluation of ion-sensitive in situ gel loaded with paeonol-solid lipid nanoparticles for intranasal drug delivery. Int J Nanomedicine. 15:3137–31360.
   PubMed Web of Science ®Google Scholar
• Surya Tej KVM, Moin A, Gowda DV, Anjali , Karunakar G, Patel NP, et al. 2016. Nano structured lipid carrier based drug delivery system. J Chem Pharm Res. 8:627–643.
   Google Scholar
• Swamy NGN, Abbas Z. 2011. Preparation and in vitro characterization of mucoadhesive hydroxypropyl guar microspheres containing amlodipine besylate for nasal administration. Indian J Pharm Sci. 73(6):608–614.
   PubMed Web of Science ®Google Scholar
• Tan JPK, Voo ZX, Lim S, Venkataraman S, Ng KM, Gao S, Hedrick JL, Yang YY. 2019. Effective encapsulation of apomorphine into biodegradable polymeric nanoparticles through a reversible chemical bond for delivery across the blood–brain barrier. Nanomed. 17:236–245.
   PubMed Web of Science ®Google Scholar
• Taymouri S, Minaiyan M, Ebrahimi F, Tavakoli N. 2020. In-vitro and in-vivo evaluation of chitosan-based thermosensitive gel containing lorazepam NLCs for the treatment of status epilepticus. IET Nanobiotechnol. 14(2):148–154.
   PubMed Web of Science ®Google Scholar
• Tonda-Turo C, Herva M, Chiono V, Ciardelli G, Spillantini MG. 2018. Influence of Drug-Carrier Polymers on Alpha-Synucleinopathies: A Neglected Aspect in New Therapies Development. Biomed Res Int. 2018:4518060–4518065.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhao X, Du J, Liu M, Feng J, Hu K. 2019. Improved brain delivery of pueraria flavones via intranasal administration of borneol-modified solid lipid nanoparticles. Nanomedicine (Lond)). 14(16):2105–2119.
   PubMed Web of Science ®Google Scholar
• Wang S, Sun Y, Zhang J, Cui X, Xu Z, Ding D. 2020. Astragalus Polysaccharides/Chitosan Microspheres for Nasal Delivery: Preparation, Optimization, Characterization, and Pharmacodynamics. Front Pharmacol. 11:1–9.
   PubMed Web of Science ®Google Scholar
• Wilhelm I, Nyúl-Tóth Á, Suciu M, Hermenean A, Krizbai IA. 2016. Heterogeneity of the blood-brain barrier. Tissue Barriers. 4(1):e1143544.
   PubMed Web of Science ®Google Scholar
• Xiang Y, Long Y, Yang Q, Zheng C, Cui M, Ci Z, Lv X, Li N, Zhang R. 2020. Pharmacokinetics, pharmacodynamics and toxicity of Baicalin liposome on cerebral ischemia reperfusion injury rats via intranasal administration. Brain Res. 1726(146503):146503.
   PubMedGoogle Scholar
• Xu D, Lu Y-R, Kou N, Hu M-J, Wang Q-S, Cui Y-L. 2020. Intranasal delivery of icariin via a nanogel-thermoresponsive hydrogel compound system to improve its antidepressant-like activity. Int J Pharm. 586:119550.
   PubMedGoogle Scholar
• Yasir M, Sara UVS. 2014. Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation. Acta Pharm Sin B. 4(6):454–463.
   PubMed Web of Science ®Google Scholar
• Zakir F, Ahmad A, Farooq U, Mirza MA, Tripathi A, Singh D, Shakeel F, Mohapatra S, Ahmad FJ, Kohli K, et al. 2020. Design and development of a commercially viable in situ nanoemulgel for the treatment of postmenopausal osteoporosis. Nanomedicine (Lond)). 15(12):1167–1187.
   PubMed Web of Science ®Google Scholar
• Zhao L, Jin W, Cruz JG, Marasini N, Khalil ZG, Capon RJ, Hussein WM, Skwarczynski M, Toth I. 2020. Development of polyelectrolyte complexes for the delivery of peptide-based subunit vaccines against group a streptococcus. Nanomaterials. 10(5):823–815.
   Web of Science ®Google Scholar
• Zhao MX, Zhu BJ. 2016. The Research and Applications of Quantum Dots as Nano-Carriers for Targeted Drug Delivery and Cancer Therapy. Nanoscale Res Lett. 11(1):207.
   PubMedGoogle Scholar
• Zhao Y, Brown MB, Khengar RH, Traynor MJ, Barata P, Jones SA. 2012. Pharmacokinetic evaluation of intranasally administered vinyl polymer-coated lorazepam microparticles in rabbits. Aaps J. 14(2):218–224.
   PubMed Web of Science ®Google Scholar